FDA Approves Merck's Dificid for Infections in Children

The U.S. Food and Drug Administration approved Merck's (NYSE: MRK) Dificid drug for children aged 6 months and older who have diarrhea caused by a specific bacterial infection called Clostridioides difficile (C. diff).